Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Systemic Thromboembolism in Pregnancy: Cerebrovascular Disease

  • Chapter
Disorders of Thrombosis and Hemostasis in Pregnancy

  • 1266 Accesses

Abstract

Stroke is a neurological emergency and one of the most common causes of long-term disability and death. Although stroke is rare at a younger age, the normal physiologic changes associated with pregnancy, combined with some of the pathophysiological processes unique to pregnancy, predispose women to develop stroke during pregnancy and the puerperium. This chapter reviews the mechanisms and risk factors for cerebrovascular disease related to pregnancy, the presenting features, diagnosis and management of these disorders, and their implications for pregnancy and delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541–53.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, Sacco RL, et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology. 2006;67:424–9.

    Article  CAS  PubMed  Google Scholar 

  3. Scott CA, Bewley S, Rudd A, Spark P, Kurinczuk JJ, Brocklehurst P, et al. Incidence, risk factors, management, and outcomes of stroke in pregnancy. Obstet Gynecol. 2012;120:318–24.

    Article  PubMed  Google Scholar 

  4. Tang CH, Wu CS, Lee TH, Hung ST, Yang CY, Lee CH, et al. Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan. Stroke. 2009;40:1162–8.

    Article  PubMed  Google Scholar 

  5. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance–United States, 1991–1999. MMWR Surveill Summ. 2003;52:1–8.

    PubMed  Google Scholar 

  6. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768–74.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Jaigobin C, Silver FL. Stroke and pregnancy. Stroke. 2000;31:2948–51.

    Article  CAS  PubMed  Google Scholar 

  8. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106:509–16.

    Article  PubMed  Google Scholar 

  9. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke. 2000;31:1274–82.

    Article  CAS  PubMed  Google Scholar 

  10. Salonen Ros H, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology. 2001;12:456–60.

    Article  CAS  PubMed  Google Scholar 

  11. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118 Suppl 1:1–203.

    PubMed  Google Scholar 

  12. Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370:1307–15.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology. 2000;55:269–74.

    Article  CAS  PubMed  Google Scholar 

  14. Coppage KH, Hinton AC, Moldenhauer J, Kovilam O, Barton JR, Sibai BM. Maternal and perinatal outcome in women with a history of stroke. Am J Obstet Gynecol. 2004;190:1331–4.

    Article  PubMed  Google Scholar 

  15. Crovetto F, Somigliana E, Peguero A, Figueras F. Stroke during pregnancy and pre-eclampsia. Curr Opin Obstet Gynecol. 2013;25:425–32.

    Article  PubMed  Google Scholar 

  16. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley Jr WG, Froelich JW, et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 2013;37:501–30.

    Article  PubMed  Google Scholar 

  17. Board of the Faculty of Clinical Radiology. Standards for intravascular contrast administration to adult patients. 2nd ed. London: The Royal College of Radiologists; 2011. BFCR(10).4.

    Google Scholar 

  18. Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics. 2007;27:1705–22.

    Article  PubMed  Google Scholar 

  19. Davie CA, O’Brien P. Stroke and pregnancy. J Neurol Neurosurg Psychiatry. 2008;79:240–5.

    Article  CAS  PubMed  Google Scholar 

  20. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2014;45:1545–88.

    Article  PubMed  Google Scholar 

  21. Treadwell SD, Thanvi B, Robinson TG. Stroke in pregnancy and the puerperium. Postgrad Med J. 2008;84:238–45.

    Article  CAS  PubMed  Google Scholar 

  22. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–236.

    Article  PubMed  Google Scholar 

  23. Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case–control study. BMJ. 2009;338:b664.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581–7.

    Google Scholar 

  25. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003–11.

    Article  CAS  PubMed  Google Scholar 

  26. Tate J, Bushnell C. Pregnancy and stroke risk in women. Womens Health (Lond Engl). 2011;7:363–74.

    Article  Google Scholar 

  27. De KJ, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38:2612–8.

    Article  Google Scholar 

  28. Electronic Medicines Compendium eMC. Datapharm Communications, London. Actilyse. Summary of product characteristics (SPC). Boehringer Ingelheim: Bracknell, West Berkshire. Last updated on 13 Oct 2013. http://www.medicines.org.uk/emc/. Accessed 31 Oct 2014.

  29. Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e601S–e36S.

    Google Scholar 

  30. National Institute for Health and Care Excellence (NICE). Stroke and TIA Clinical knowledge summaries. 2013. http://cks.nice.org.uk/stroke-and-tia. Accessed 30 Oct 2014.

  31. Cuthill JA, Young S, Greer IA, Oldroyd K. Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for caesarean section. Int J Obstet Anesth. 2005;14:167–71.

    Article  CAS  PubMed  Google Scholar 

  32. Klinzing P, Markert UR, Liesaus KF, Peiker G. Case report: successful pregnancy and delivery after myocardial infarction and essential thrombocythemia treated with clopidrogel. Clin Exp Obstet Gynecol. 2001;28:215–6.

    CAS  PubMed  Google Scholar 

  33. Taguchi K. Pregnancy in patients with a prosthetic heart valve. Surg Gynecol Obstet. 1977;145:206–8.

    CAS  PubMed  Google Scholar 

  34. Kusters DM, Hassani Lahsinoui H, van de Post JA, Wiegman A, Wijburg FA, Kastelein JJ, Hutten BA. Statin use during pregnancy: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2012;10:363–78.

    Article  CAS  PubMed  Google Scholar 

  35. Lockshin MD, Pierangeli SS. Statins for the treatment of obstetric complications in antiphospholipid syndrome? J Reprod Immunol. 2010;84:206; author reply 206–7.

    Article  CAS  PubMed  Google Scholar 

  36. Electronic Medicines Compendium eMC. Datapharm Communications, London. Simvastatin 10mg tablets -summary product characteristics (SPC) https://www.medicines.org.uk/emc/medicine/. Accessed 31 Oct 2014.

  37. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47:440–5.

    Article  PubMed  Google Scholar 

  38. Petty GW, Khandheria BK, Meissner I, Whisnant JP, Rocca WA, Christianson TJ, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81:602–8.

    Article  PubMed  Google Scholar 

  39. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case–control studies. Neurology. 2000;55:1172–9.

    Article  CAS  PubMed  Google Scholar 

  40. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157:47–58.

    Article  CAS  PubMed  Google Scholar 

  41. Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, de Jesus GR, Erkan D. The estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis. Arthritis Care Res (Hoboken). 2013;65:1869–73.

    Article  CAS  Google Scholar 

  42. Arachchillage DR, Machin SJ, Cohen H. Antithrombotic treatment for stroke associated with antiphospholipid antibodies. Expert Rev Hematol. 2014;7:169–72.

    Article  PubMed  Google Scholar 

  43. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum. 2007;57:1487–95.

    Article  PubMed  Google Scholar 

  44. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010;8:237–42.

    Article  CAS  PubMed  Google Scholar 

  45. Langevitz P, Livneh AF, Dulitzki MF, Pauzner RF, Many AF, Soriano DF, Pras M. Outcome of pregnancy in three patients with primary antiphospholipid syndrome after stroke. Semin Arthritis Rheum. 1998;28:26–30.

    Article  CAS  PubMed  Google Scholar 

  46. Stone S, Hunt BJ, Khamashta MA, Bewley SJ, Nelson-Piercy C. Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J Thromb Haemost. 2005;3:243–5.

    Article  CAS  PubMed  Google Scholar 

  47. Fischer-Betz R, Specker CF, Brinks RF, Schneider M. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study. Lupus. 2012;21:1183–9.

    Article  CAS  PubMed  Google Scholar 

  48. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R, Erkan D, Krilis S, Machin S, Pengo V, Pierangeli S, Tektonidou M, Khamashta M. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 2011;20:206–18.

    Google Scholar 

  49. Erkan D, Vega J, Ramón G, Kozora E, Lockshin MD. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum. 2013;65(2):464–71.

    Google Scholar 

  50. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore). 1981;60:413–28.

    Article  CAS  Google Scholar 

  51. Scully M, Yarranton H, Liesner R, Cavenagh J, Hunt B, Benjamin S, et al. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol. 2008;142:819–26.

    Article  PubMed  Google Scholar 

  52. Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004;44:1149–58.

    Article  PubMed  Google Scholar 

  53. Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158:323–35.

    Article  PubMed  Google Scholar 

  54. Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, Tracy RP. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thromb Haemost. 1998;79:912–5.

    CAS  PubMed  Google Scholar 

  55. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, Bovill EG. Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke. 1999;30:2547–53.

    Article  CAS  PubMed  Google Scholar 

  56. Juul K, Tybjaerg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood. 2002;100:3–10.

    Article  CAS  PubMed  Google Scholar 

  57. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912–7.

    Article  CAS  PubMed  Google Scholar 

  58. Ridker PM, Hennekens CHFAU, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999–1004.

    Article  CAS  PubMed  Google Scholar 

  59. Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol. 2004;61:1652–61.

    Article  PubMed  Google Scholar 

  60. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146:948–57.

    Article  CAS  PubMed  Google Scholar 

  61. Boulet SL, Okoroh EM, Azonobi I, Grant A, Hooper CH. Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population. Matern Child Health J. 2013;17:200–7.

    Article  PubMed Central  PubMed  Google Scholar 

  62. Kissela B, Schneider AF, Kleindorfer DF, Khoury JF, Miller RF, Alwell KF, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35:426–31.

    Article  PubMed  Google Scholar 

  63. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–94.

    CAS  PubMed  Google Scholar 

  64. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997;102:171–7.

    Article  CAS  PubMed  Google Scholar 

  65. Powars DF, Wilson BF, Imbus CF, Pegelow CF, Allen J. The natural history of stroke in sickle cell disease. Am J Med. 1978;65(3):461–71.

    Article  CAS  PubMed  Google Scholar 

  66. Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med. 2004;117:755–61.

    Article  PubMed  Google Scholar 

  67. Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. British Committee for Standards in Haematology Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010;149:352–75.

    Article  CAS  PubMed  Google Scholar 

  68. McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, et al.; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol. 2005;130:174–95.

    Google Scholar 

  69. Hillmen P, Richards SJ. Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2000;108:470–9.

    Article  CAS  PubMed  Google Scholar 

  70. Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003;102:3587–91.

    Article  CAS  PubMed  Google Scholar 

  71. Socié G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet. 1996;348:573–7.

    Article  PubMed  Google Scholar 

  72. Tiu R, Yacoub HF, Maciejewski JF, Sila CA. Recurrent ischemic stroke in paroxysmal nocturnal hemoglobinuria: paroxysmal nocturnal hemoglobinuria or missed patent foramen ovale? J Stroke Cerebrovasc Dis. 2009;18:409–10.

    Article  PubMed  Google Scholar 

  73. Petras M, Tatarkova ZF, Kovalska MF, Mokra DF, Dobrota DF, Lehotsky JF, Drgova A. Hyperhomocysteinemia as a risk factor for the neuronal system disorders. J Physiol Pharmacol. 2014;65:15–23.

    CAS  PubMed  Google Scholar 

  74. Martí-Carvajal AJ, Solà I, Lathyris D, Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2009;(4):CD006612.

    Google Scholar 

  75. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005;365:224–32.

    Article  CAS  PubMed  Google Scholar 

  76. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al.; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–8.

    Google Scholar 

  77. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al.; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–77.

    Google Scholar 

  78. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291(5):565–75.

    Article  CAS  PubMed  Google Scholar 

  79. Martí-Carvajal AJ, Solà I, Lathyris D, Karakitsiou DE, Simancas-Racines D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2013;(4):CD006612.

    Google Scholar 

  80. Jeng JS, Tang SC, Yip PK. Stroke in women of reproductive age: comparison between stroke related and unrelated to pregnancy. J Neurol Sci. 2004;221:25–9.

    Article  PubMed  Google Scholar 

  81. Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246–54.

    Article  PubMed  Google Scholar 

  82. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326:845.

    Article  PubMed Central  PubMed  Google Scholar 

  83. Mortimer AM, Bradley MD, Likeman M, Stoodley NG, Renowden SA. Cranial neuroimaging in pregnancy and the post-partum period. Clin Radiol. 2013;68:500–8.

    Article  CAS  PubMed  Google Scholar 

  84. Sawle GV, Ramsay MM. The neurology of pregnancy. J Neurol Neurosurg Psychiatry. 1998;64:711–25.

    Article  CAS  PubMed  Google Scholar 

  85. Katz BS, Fugate JE, Ameriso SF, Pujol-Lereis VA, Mandrekar J, Flemming KD, et al. Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol. 2014;71:68–73.

    Article  PubMed  Google Scholar 

  86. Easton JD. Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy? Cerebrovasc Dis. 1998;8:53–8.

    Article  CAS  PubMed  Google Scholar 

  87. National Institute for Health and Care Excellence (NICE). NICE clinical guideline 107. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. 2010. https://www.nice.org.uk/guidance/CG107. Accessed 31 Oct 2014.

  88. RCOG Greentop guidelines. Severe pre-eclampsia/eclampsia, guideline. Guideline no. 10A. London: Royal College of Obstetricians and Gynaecologists. 2006. http://www.rcog.org.uk/guidelines.

  89. Kumar S, Wong G, Maysky M, Shulman M, Olenchock S, Falzon-Kirby M, et al. Amniotic fluid embolism complicated by paradoxical embolism and disseminated intravascular coagulation. Am J Crit Care. 2010;19:379–82.

    Article  PubMed  Google Scholar 

  90. Huang CY, Chen CA, Hsieh CY, Cheng WF. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review. Int J Gynecol Cancer. 2007;17:1166–71.

    Article  PubMed  Google Scholar 

  91. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F, ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720–5.

    Article  PubMed  Google Scholar 

  92. Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke. 1993;24:1880–4.

    Article  CAS  PubMed  Google Scholar 

  93. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al.; American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92.

    Google Scholar 

  94. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6:162–70.

    Article  CAS  PubMed  Google Scholar 

  95. Star M, Flaster M. Advances and controversies in the management of cerebral venous thrombosis. Neurol Clin. 2013;31:765–83.

    Article  PubMed  Google Scholar 

  96. Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597–600.

    Article  PubMed  Google Scholar 

  97. Fink JN, McAuley DL. Safety of anticoagulation for cerebral venous thrombosis associated with intracerebral hematoma. Neurology. 2001;57:1138–9.

    Article  CAS  PubMed  Google Scholar 

  98. Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev. 2011;(8):CD002005.

    Google Scholar 

  99. Einhäupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, Masuhr F, European Federation of Neurological Societies. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010;17:1229–35.

    Article  PubMed  Google Scholar 

  100. Khan M, Wasay M. Haemorrhagic strokes in pregnancy and puerperium. Int J Stroke. 2013;8:265–72.

    Article  PubMed  Google Scholar 

  101. Liang CC, Chang SD, Lai SL, Hsieh CC, Chueh HY, Lee TH. Stroke complicating pregnancy and the puerperium. Eur J Neurol. 2006;13:1256–60.

    Article  PubMed  Google Scholar 

  102. Mas JL, Lamy C. Stroke in pregnancy and the puerperium. J Neurol. 1998;245:305–13.

    Article  CAS  PubMed  Google Scholar 

  103. Horton JC, Chambers WA, Lyons SL, Adams RD, Kjellberg RN. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 1990;27:867–71; discussion 871–2.

    Article  CAS  PubMed  Google Scholar 

  104. Liu XJ, Wang S, Zhao YL, Teo M, Guo P, Zhang D, et al. Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium. Neurology. 2014;82:1798–803.

    Article  PubMed Central  PubMed  Google Scholar 

  105. Agarwal N, Guerra JC, Gala NB, Agarwal P, Zouzias A, Gandhi CD, et al. Current treatment options for cerebral arteriovenous malformations in pregnancy: a review of the literature. World Neurosurg. 2014;81:83–90.

    Article  PubMed  Google Scholar 

  106. Shaw P, Duncan A, Vouyouka A, Ozsvath K. Radiation exposure and pregnancy. J Vasc Surg. 2011;53(1 Suppl):28S–34.

    Article  PubMed  Google Scholar 

  107. Tiel Groenestege AT, Rinkel GJ, van der Bom JG, Algra A, Klijn CJ. The risk of aneurysmal subarachnoid hemorrhage during pregnancy, delivery, and the puerperium in the Utrecht population: case-crossover study and standardized incidence ratio estimation. Stroke. 2009;40:1148–51.

    Article  PubMed  Google Scholar 

  108. Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf). 2011;74:9–20.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, UK

    Deepa Jayakody Arachchillage MBBS, MRCP, FRCPath & Hannah Cohen MB ChB, MD, FCRP, FRCPath

  2. Institute of Women’s Health, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, UK

    Patrick O’Brien MB BCh, FRCOG, FICOG, FFSRH

  3. Department of Clinical Neurosciences, The Royal Free Hampstead NHS Trust, Pond Street, London, NW3 2QG, UK

    Charlie Davie MB ChB, MD, FRCP

Authors
  1. Deepa Jayakody Arachchillage MBBS, MRCP, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick O’Brien MB BCh, FRCOG, FICOG, FFSRH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charlie Davie MB ChB, MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hannah Cohen MB ChB, MD, FCRP, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deepa Jayakody Arachchillage MBBS, MRCP, FRCPath .

Editor information

Editors and Affiliations

  1. Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom

    Hannah Cohen

  2. Institute for Women's Health, University College London Hospitals NHS Foundation Trust, London, United Kingdom

    Patrick O'Brien

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Arachchillage, D.J., O’Brien, P., Davie, C., Cohen, H. (2015). Systemic Thromboembolism in Pregnancy: Cerebrovascular Disease. In: Cohen, H., O'Brien, P. (eds) Disorders of Thrombosis and Hemostasis in Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-319-15120-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15120-5_6

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15119-9

  • Online ISBN: 978-3-319-15120-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation